Search research articles
Contact Us
Filters
Showing results (1-10 of 160) with videos related to
Page
of 16
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 28, 2019
PET is necessary to make the next step forward in understanding MS pathophysiology - Yes
Benedetta Bodini, Bruno Stankoff
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 26, 2025
Should disease-modifying therapy be discontinued in older patients with stable MS after long-term clinical and radiological stability? Yes
Géraldine Androdias, Bruno Stankoff
Brain Plasticity (Amsterdam, Netherlands)
|
May 17, 2018
Imaging Central Nervous System Demyelination and Remyelination by Positron-Emission Tomography
Benedetta Bodini, Bruno Stankoff
Handbook of Clinical Neurology
|
February 11, 2014
Demyelination in multiple sclerosis
Catherine Lubetzki, Bruno Stankoff
Brain : a Journal of Neurology
|
May 26, 2018
Can we use regional grey matter atrophy sequence to stage neurodegeneration in multiple sclerosis?
Bruno Stankoff, Céline Louapre
Frontiers in Immunology
|
January 21, 2015
Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab
Caroline Antoniol, Bruno Stankoff
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 31, 2018
Is it time to conduct phase 3 clinical trials of sex hormones in MS - Commentary
Anne-Laure Dubessy, Bruno Stankoff
La Revue Du Praticien
|
May 31, 2022
[Multiple sclerosis: what therapeutic perspectives ?]
Céline Louapre, Bruno Stankoff, Benedetta Bodini
Current Opinion in Neurology
|
May 14, 2005
Promoting repair in multiple sclerosis: problems and prospects
Catherine Lubetzki, Anna Williams, Bruno Stankoff
Presse Medicale (Paris, France : 1983)
|
March 31, 2015
Advanced imaging tools to investigate multiple sclerosis pathology
Benedetta Bodini, Céline Louapre, Bruno Stankoff
Page
of 16
Search research articles
Search
Showing results (1-10 of 160) with videos related to
Sort By:
Page
of 16
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 28, 2019
PET is necessary to make the next step forward in understanding MS pathophysiology - Yes
Benedetta Bodini, Bruno Stankoff
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 26, 2025
Should disease-modifying therapy be discontinued in older patients with stable MS after long-term clinical and radiological stability? Yes
Géraldine Androdias, Bruno Stankoff
Brain Plasticity (Amsterdam, Netherlands)
|
May 17, 2018
Imaging Central Nervous System Demyelination and Remyelination by Positron-Emission Tomography
Benedetta Bodini, Bruno Stankoff
Handbook of Clinical Neurology
|
February 11, 2014
Demyelination in multiple sclerosis
Catherine Lubetzki, Bruno Stankoff
Brain : a Journal of Neurology
|
May 26, 2018
Can we use regional grey matter atrophy sequence to stage neurodegeneration in multiple sclerosis?
Bruno Stankoff, Céline Louapre
Frontiers in Immunology
|
January 21, 2015
Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab
Caroline Antoniol, Bruno Stankoff
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 31, 2018
Is it time to conduct phase 3 clinical trials of sex hormones in MS - Commentary
Anne-Laure Dubessy, Bruno Stankoff
La Revue Du Praticien
|
May 31, 2022
[Multiple sclerosis: what therapeutic perspectives ?]
Céline Louapre, Bruno Stankoff, Benedetta Bodini
Current Opinion in Neurology
|
May 14, 2005
Promoting repair in multiple sclerosis: problems and prospects
Catherine Lubetzki, Anna Williams, Bruno Stankoff
Presse Medicale (Paris, France : 1983)
|
March 31, 2015
Advanced imaging tools to investigate multiple sclerosis pathology
Benedetta Bodini, Céline Louapre, Bruno Stankoff
Page
of 16